GlassScriptPhysician profile
Chanhaeng Rhee
NPI 1649464280
$1,722.09
in general payments reported to CMS, 2019-2025
14 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $516 · 2024: $1,068 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,706 · Education: $16.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.82 |
| Education | $16.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $370.22 | 2023 | Tepezza |
| Tandem Diabetes Care, INC. | $257.37 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $255.90 | 2023-2024 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $249.57 | 2024 | |
| Novo Nordisk INC | $143.86 | 2023-2025 | Ozempic, Rybelsus |
| Corcept Therapeutics | $132.69 | 2024 | Korlym |
| Kyowa Kirin, INC. | $125.00 | 2024 | Crysvita |
| Alexion Pharmaceuticals, INC. | $59.79 | 2024-2025 | Strensiq |
| Lilly USA, LLC | $25.80 | 2023 | Taltz |
| Dexcom, INC. | $23.31 | 2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $21.25 | 2024 | Minimed 780g |
| Mannkind Corporation | $20.88 | 2023 | Afrezza |
| Amryt Pharma Holdings LTD | $19.32 | 2023 | Mycapssa |
| Recordati_rare_diseases_inc. | $17.13 | 2024 | Signifor Lar, Isturisa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chanhaeng Rhee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.